Loading organizations...
§ Private Profile · Warsaw, Poland
AI-driven platform for symptom analysis, preliminary diagnosis, and patient triage, supporting healthcare, insurance, and pharma to improve.
Infermedica has raised $13.7M across 2 funding rounds.
Key people at Infermedica.
Infermedica has raised $13.7M in total across 2 funding rounds.
Infermedica, based in Wrocław, Poland, develops an AI-driven platform for symptom analysis, preliminary diagnosis, and patient triage. The SaaS platform combines medical expertise with algorithms to provide personalized health advice, supporting healthcare providers, insurers, and pharma companies across 35 countries. It has performed over 25 million health checkups with 96% accuracy, available in 26 languages. It secured a $30 million Series B in January 2022 led by One Peak, building on a $10 million Series A in August 2020 from EBRD and Heal Capital, and counts Microsoft among its customers. With 180 employees as of 2021, Infermedica was founded in 2012 by Piotr Orzechowski, alongside Roberto Sicconi and Irv Loh as founding medical figures. Its business model centers on saaS platform licensed to healthcare providers, insurers, and pharmaceutical companies.
Infermedica has raised $13.7M in total across 2 funding rounds.
Infermedica's investors include Maria Barsuk, Christian Weiss, Dreamit Ventures, Inovo Venture Partners, Karma Ventures, Margus Uudam, Muller Medien.
Infermedica has raised $13.7M across 2 funding rounds. Most recently, it raised $10.0M Series A in August 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 6, 2020 | $10M Series A | Maria Barsuk, Christian Weiss | Dreamit Ventures, Inovo Venture Partners, Karma Ventures | Announced |
| Jun 5, 2019 | $3.6M Venture Round | Margus Uudam | Dreamit Ventures, Inovo Venture Partners, Muller Medien | Announced |
Key people at Infermedica.
Infermedica is a Polish-founded digital healthcare company specializing in AI-powered solutions for symptom analysis, patient triage, and care navigation. It builds products like the Symptom Checker, Call Center Triage, Pre-visit Intake, and Infermedica API to serve health plans, insurers, governments, telemedicine providers, healthcare organizations, and pharmaceutical companies.[1][2][3][5] These tools solve critical problems such as doctor shortages (projected 14 million global deficit by 2030), limited access to basic care (affecting 50% of the world population), and unsustainable systems (e.g., potential $210 billion annual U.S. savings from better care).[3] With over 25 million health checkups performed, 96% condition accuracy, support for 26 languages, and operations in 35 countries, Infermedica demonstrates strong growth, including an 80% team expansion to 180 specialists in 2021 and serving all 28 million Australians via national triage.[1][2][3]
Infermedica was founded in 2012 in Poland by Piotr Orzechowski, who remains CEO and drew from orienting questions around health symptoms to create accessible pre-diagnosis tools.[1][2] Orzechowski's vision emerged from recognizing gaps in healthcare delivery despite advanced technology, aiming to automate primary care from symptom assessment to outcomes.[1][3] Early traction built through combining AI algorithms with medical expertise, leading to pivotal expansions like Google for Startups support and scaling to over 200 employees, 100+ clients, and nationwide adoption in Australia.[2][4] This evolution humanizes healthcare by demystifying symptoms and guiding patients efficiently.[2]
Infermedica stands out in AI healthcare through its trusted, human-centric platform that integrates medical rigor with technology:
Infermedica rides the AI-driven digital health transformation trend, addressing post-pandemic pressures like clinician shortages and rising costs amid global healthcare deficits.[1][3] Timing is ideal as telemedicine surges, with AI enabling scalable triage to alleviate overburdened systems—exemplified by serving Australia's entire population and 100+ providers worldwide.[2][5][9] Market forces like cost-saving potential ($210B U.S. annually) and accessibility demands (50% global population gap) favor its model, influencing the ecosystem by setting standards for trusted AI that augments professionals, improves patient flow, and integrates with insurers/pharma for targeted care.[3][5][6] It bridges medicine and tech, fostering efficient, equitable primary care globally.[7]
Infermedica is poised for accelerated growth as AI adoption in healthcare deepens, potentially expanding its platform to more use cases like precision pharma campaigns and rural outreach.[5] Trends like multimodal AI, regulatory trust in medical LLMs, and global telehealth mandates will shape its path, enhancing accuracy beyond 96% and client base past 35 countries.[3][6] Its influence may evolve from triage leader to full primary care orchestrator, further reducing inefficiencies and empowering underserved regions—reinforcing its mission to make quality care accessible everywhere, starting from that 2012 spark in Poland.[1][2]
